Understanding Multiple Sclerosis Treatment Options

What Is Multiple Sclerosis and How Is It Treated?

Multiple sclerosis (MS) is a disease where the immune system attacks the protective coating around nerve fibers in the brain and spinal cord. This coating, called myelin, helps nerve signals travel quickly through the body. When myelin gets damaged, messages between the brain and the rest of the body slow down or stop completely. This can cause symptoms like fatigue, difficulty walking, vision problems, and numbness.

According to the National MS Society, approximately 2.3 million people worldwide have MS, with about 1 million living in the United States. MS affects each person differently. Some people have mild symptoms that stay stable for years, while others experience symptoms that get worse over time.

Treatment for MS focuses on three main goals: slowing disease progression, managing symptoms, and improving quality of life. No cure currently exists, but many treatment options can help control the disease and reduce how often and how severely symptoms appear. The type of treatment recommended depends on which form of MS a person has, how active the disease is, and how the individual responds to medications.

Modern MS treatment is very different from what was available 20 or 30 years ago. In 1993, interferon beta-1b became the first FDA-approved disease-modifying therapy (DMT) for MS. Today, there are over 20 DMTs available, giving people and their doctors many options to choose from. Treatment has become increasingly personalized, meaning doctors select medications based on each person's specific disease pattern and medical history.

Practical Takeaway: Understanding MS treatment starts with learning about the three types of MS (relapsing-remitting, primary progressive, and secondary progressive) and how each responds differently to medications. A neurologist specializing in MS can explain which treatment approach might work best for an individual's situation.

Disease-Modifying Therapies: The Core of MS Treatment

Disease-modifying therapies (DMTs) are medications that slow or reduce how active MS is in the body. These drugs work by calming the immune system so it stops attacking myelin. DMTs are considered the foundation of MS treatment and are typically recommended soon after diagnosis, even if symptoms are mild.

There are several categories of DMTs, each working in different ways. Interferon-based therapies like interferon beta-1a and interferon beta-1b have been used since the 1990s. These drugs help regulate immune function and reduce inflammation. Glatiramer acetate works by training immune cells to become less aggressive toward myelin. Monoclonal antibodies like natalizumab, ocrelizumab, and alemtuzumab directly target specific immune cells or proteins that cause inflammation.

Newer oral DMTs include fingolimod, teriflunomide, and dimethyl fumarate. These pills are taken by mouth, making them easier to use than injectable medications. Fingolimod works by trapping immune cells in lymph nodes so they cannot attack the nervous system. Dimethyl fumarate reduces immune cell numbers and inflammatory proteins.

Research shows that starting DMT treatment early improves long-term outcomes. A study published in JAMA Neurology in 2017 found that people who started DMTs within 6 months of their first MS symptom had fewer relapses and less disability progression over 10 years compared to those who delayed treatment. About 85% of people with relapsing-remitting MS, the most common form, are prescribed a DMT at some point.

Choosing the right DMT involves weighing effectiveness, side effects, how often the medication is taken, and personal health factors. Some DMTs require regular blood tests to monitor liver or kidney function. Others need regular eye exams or heart monitoring. A person's neurologist discusses these factors to find the best option for their situation.

Practical Takeaway: Learning about the different categories of DMTs—injectables, oral medications, and infusions—helps people understand what to expect with treatment. Each category has different schedules and monitoring requirements that affect daily life differently.

Managing Relapses and Acute Symptoms

A relapse, also called an exacerbation or flare, happens when inflammation in the nervous system causes new or worsening symptoms. Relapses can last days, weeks, or even months. Common symptoms during a relapse include vision loss, weakness, numbness, balance problems, and fatigue. Not all MS relapses require treatment, but many do benefit from medications that reduce inflammation quickly.

Corticosteroids are the standard treatment for moderate to severe MS relapses. Methylprednisolone, given intravenously (through an IV), is most commonly used. A typical course involves high-dose methylprednisolone given daily for 3 to 5 days, sometimes followed by oral corticosteroids. Corticosteroids work by suppressing immune activity and reducing inflammation around damaged nerves. Research shows they can shorten relapses by a few days and speed recovery of function.

Some people receive corticosteroids at home through an IV line, while others go to a hospital or infusion center for treatment. A 2020 study in Multiple Sclerosis Journal found that about 40% of people with relapsing-remitting MS experience at least one relapse in a given year, though this number varies widely based on disease activity and DMT use.

If a person does not respond well to corticosteroids, other options exist. Plasma exchange (also called plasmapheresis) is sometimes used for severe relapses. This procedure removes certain antibodies and proteins from the blood that contribute to inflammation. Intravenous immunoglobulin (IVIG) is another option—it supplies healthy antibodies that can help regulate immune activity. Both of these treatments are less common than corticosteroids but may help when standard treatment is not effective.

Managing relapses also includes having a clear plan with a neurologist about when to seek treatment. Some people benefit from keeping a symptom diary to recognize new symptoms early. Having emergency contact information for the neurology office and knowing where to go for urgent care helps people respond quickly when a relapse occurs.

Practical Takeaway: Understanding the difference between new or worsening symptoms that need medical attention and fluctuating symptoms that are part of normal MS patterns helps people make better decisions about when to contact their doctor.

Treating Specific MS Symptoms

Beyond slowing disease progression, MS treatment includes managing specific symptoms that affect daily life. Different symptoms require different approaches, and a comprehensive care plan often includes several medications and therapies working together.

Fatigue is one of the most common and disabling MS symptoms, affecting up to 80% of people with MS. Medications like amantadine can help, though research shows mixed results. Behavioral approaches often work better—these include energy management strategies, regular exercise, good sleep habits, and treating other conditions like depression or sleep disorders that worsen fatigue. Cognitive behavioral therapy, a type of counseling, helps some people develop better coping strategies.

Spasticity, a stiffness or involuntary tightening of muscles, affects many people with MS. Baclofen is the most commonly prescribed medication for spasticity. It works by calming nerve signals that cause muscle tightness. For more severe spasticity that doesn't respond to pills, a baclofen pump can deliver medication directly to the spinal cord. Physical therapy and stretching also play an important role in managing spasticity and maintaining range of motion.

Pain affects about 50% of people with MS. Pain can come from nerve damage (neuropathic pain) or from muscle tightness and spasticity (musculoskeletal pain). Medications like pregabalin, gabapentin, or tricyclic antidepressants help nerve pain. Over-the-counter pain relievers, physical therapy, and heat or cold therapy help musculoskeletal pain. Some people benefit from pain management specialists who focus specifically on treating chronic pain.

Bladder and bowel problems are common in MS. These symptoms may include urinary urgency, frequent urination, or difficulty controlling bowel movements. Treatment depends on the specific problem. For urinary urgency, medications like oxybutynin or tolterodine reduce bladder contractions. For difficulty emptying the bladder, intermittent catheterization—inserting a thin tube to drain the bladder—is often recommended. A u